These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 23870817)

  • 1. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.
    Jamal SA; Vandermeer B; Raggi P; Mendelssohn DC; Chatterley T; Dorgan M; Lok CE; Fitchett D; Tsuyuki RT
    Lancet; 2013 Oct; 382(9900):1268-77. PubMed ID: 23870817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
    Navaneethan SD; Palmer SC; Craig JC; Elder GJ; Strippoli GF
    Am J Kidney Dis; 2009 Oct; 54(4):619-37. PubMed ID: 19692157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
    Patel L; Bernard LM; Elder GJ
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis.
    Jamal SA; Fitchett D; Lok CE; Mendelssohn DC; Tsuyuki RT
    Nephrol Dial Transplant; 2009 Oct; 24(10):3168-74. PubMed ID: 19622572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis.
    Habbous S; Przech S; Acedillo R; Sarma S; Garg AX; Martin J
    Nephrol Dial Transplant; 2017 Jan; 32(1):111-125. PubMed ID: 27651467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACP Journal Club. Review: non-calcium-based phosphate binders reduce mortality compared with calcium-based binders in CKD.
    Parikh CR
    Ann Intern Med; 2013 Nov; 159(10):JC2. PubMed ID: 24247692
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
    Assimon MM; Mousa S; Shaker O; Pai AB
    Consult Pharm; 2010 Jan; 25(1):41-54. PubMed ID: 20211816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-based phosphate binders and chronic kidney disease.
    Hiremath S; Akbari A
    Lancet; 2014 Jan; 383(9913):216. PubMed ID: 24439735
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis.
    Sekercioglu N; Thabane L; Díaz Martínez JP; Nesrallah G; Longo CJ; Busse JW; Akhtar-Danesh N; Agarwal A; Al-Khalifah R; Iorio A; Guyatt GH
    PLoS One; 2016; 11(6):e0156891. PubMed ID: 27276077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?
    St. Peter WL; Wazny LD; Weinhandl E; Cardone KE; Hudson JQ
    Drugs; 2017 Jul; 77(11):1155-1186. PubMed ID: 28584909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.
    Zhai CJ; Yang XW; Sun J; Wang R
    Int Urol Nephrol; 2015 Mar; 47(3):527-35. PubMed ID: 25399356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients.
    Tonelli M; Wiebe N; Culleton B; Lee H; Klarenbach S; Shrive F; Manns B;
    Nephrol Dial Transplant; 2007 Oct; 22(10):2856-66. PubMed ID: 17906326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The demise of calcium-based phosphate binders.
    Ortiz A; Sanchez-Niño MD
    Lancet; 2013 Oct; 382(9900):1232-4. PubMed ID: 23870814
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of phosphate binders in chronic kidney disease.
    Ketteler M; Biggar PH
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):413-20. PubMed ID: 23736841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders.
    Komaba H; Wang M; Taniguchi M; Yamamoto S; Nomura T; Schaubel DE; Smith AR; Zee J; Karaboyas A; Bieber B; Fukagawa M; Tentori F
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1489-1497. PubMed ID: 28724618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of calcium acetate with calcium carbonate as phosphate binder in patients on maintenance haemodialysis.
    Saif I; Halim A; Altaf A; Saif M; Khalid M; Ahmad D; Imran H
    J Ayub Med Coll Abbottabad; 2007; 19(4):26-8. PubMed ID: 18693591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
    Mohammed I; Hutchison AJ
    J Ren Care; 2009 Mar; 35 Suppl 1():65-70. PubMed ID: 19222734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of comparative effectiveness without evidence of effectiveness: the case of phosphate binders in CKD.
    Uhlig K
    Am J Kidney Dis; 2014 Jan; 63(1):13-5. PubMed ID: 24200463
    [No Abstract]   [Full Text] [Related]  

  • 19. Design and baseline characteristics of the LANDMARK study.
    Ogata H; Fukagawa M; Hirakata H; Kaneda H; Kagimura T; Akizawa T;
    Clin Exp Nephrol; 2017 Jun; 21(3):531-537. PubMed ID: 27405619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.
    St Peter WL; Liu J; Weinhandl E; Fan Q
    Am J Kidney Dis; 2008 Mar; 51(3):445-54. PubMed ID: 18295060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.